EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER

This adverse event was reported 1769 times

These drugs are most commonly taken by patients reporting EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER:

# Drug Count
0 METHOTREXATE SODIUM 626
1 METHOTREXATE 558
2 TACROLIMUS 507
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 433
4 TACROLIMUS OINTMENT 0.1% 433
5 MYCOPHENOLATE MOFETIL 426
6 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 426
7 CYCLOSPORINE 387
8 PREDNISOLONE 337
9 PREDNISOLONE ORAL 337
See all common drugs associated with EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER

EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OMIDUBICEL-ONLV 1 0.0455
1 EDETATE CALCIUM DISODIUM 1 0.0250
2 ANTI-THYMOCYTE GLOBULIN (RABBIT) 118 0.0145
3 DEXCHLORPHENIRAMINE MALEATE 7 0.0070
4 DEXRAZOXANE FOR INJECTION 6 0.0064
5 GANCICLOVIR SODIUM 67 0.0063
6 LULICONAZOLE 1 0.0057
7 BUSULFAN 78 0.0049
8 EQUINE THYMOCYTE IMMUNE GLOBULIN 5 0.0048
9 PRALATREXATE 3 0.0046
See all drugs enriched for association with EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER